Original Article

Patient Interest in Mental Health Screening by Endocrinologists

Authors: M. Shajjad Hossain, MD, Joshua Fogel, PhD, Damilola Ashorobi, MD, Salini Kumar, MD, David S. Rosenthal, MD

Abstract

Objectives: Endocrine disorders often coexist with mental health issues. Little is known about patient beliefs regarding endocrinologists’ involvement in mental health screening. We studied the beliefs of patients with endocrine disorders regarding endocrinologists’ asking about mental health and whether patients perceive that endocrinologists are capable of recognizing mental health concerns.

Methods: This was a cross-sectional survey of 500 adults with endocrine disorders with either diabetes mellitus or glandular diseases of the thyroid, adrenal, pituitary, or gonads conducted at a public hospital endocrinology clinic near New York City. Depressive symptoms were measured with the Patient Health Questionnaire-9 scale and anxiety symptoms were measured with the Generalized Anxiety Disorder-7 scale.

Results: More than half of those surveyed expressed interest in their endocrinologist asking about mental health, depression, anxiety, and/or psychosocial stress. The belief that an endocrinologist can determine whether a patient has mental health issues, depression, anxiety, and psychosocial stress had mean values between neutral and agree. Patients who wanted their endocrinologist to ask about these topics had significantly (all analyses P < 0.001) greater depressive and/or anxiety symptoms than those who did not want their endocrinologist to ask about these topics.

Conclusions: Many patients with endocrine disorders want endocrinologists to ask about their mental health. We recommend that endocrinologists consider incorporating mental health screening for depression and anxiety into routine patient care because many patients would welcome this approach.
Posted in: Dermatology15

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Salvador J, Gutierrez G, Llavero M, et al. Endocrine disorders and psychiatric manifestations. In: Portincasa P, Frühbeck G, Nathoe HM, eds. Endocrinology and Systemic Diseases. New York: Springer; 2019:1–35.
 
2. Lindekilde N, Rutters F, Henriksen JE, et al. Psychiatric disorders as risk factors for type 2 diabetes: an umbrella review of systematic reviews with and without meta-analyses. Diabetes Res Clin Pract 2021;176:108855.
 
3. Kershaw KA, Storer B, Braund T, et al. The prevalence of anxiety in adult endocrinology outpatients: a systematic review and meta-analysis. Psychoneuroendocrinology 2023;158:106357.
 
4. Chaturvedi SK, Manche Gowda S, Ahmed HU, et al. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus. Gen Psychiatr 2019;32:e100076.
 
5. Siegmann EM, Müller HHO, Luecke C, et al. Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis. JAMA Psychiatry 2018; 75:577–584.
 
6. Mishra KK, Sawant N, Garg S. Management of psychiatric disorders in patients with endocrine disorders. Indian J Psychiatry 2022;64(Suppl 2):S402–S413.
 
7. Smith KJ, Schmitz N. Association of depression and anxiety symptoms with functional disability and disability days in a community sample with type 2 diabetes. Psychosomatics 2014;55:659–667.
 
8. Anderson KS, Howard KJ, Haskard-Zolnierek KB, et al. Using the biopsychosocial approach to identify factors associated with major depressive disorder for individuals with hypothyroidism. Issues Ment Health Nurs 2022;43:755–765.
 
9. Wong JJ, Hanes S, Iturralde E, et al. Do youth want psychosocial screenings in diabetes clinic? Profiles of acceptability. J Pediatr Psychol 2021;46:332–340.
 
10. Corathers SD, Kichler J, Jones NH, et al. Improving depression screening for adolescents with type 1 diabetes. Pediatrics 2013;132:e1395–e1402.
 
11. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–613.
 
12. Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care 2008;46:266–274.
 
13. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–396.
 
14. Poghosyan L, Norful AA, Ghaffari A, et al. Mental health delivery in primary care: the perspectives of primary care providers. Arch Psychiatr Nurs 2019;33:63–67.
 
15. Siu AL, US Preventive Services Task Force (USPSTF), Bibbins-Domingo K, et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA 2016;315:380–387.
 
16. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003;41:1284–1292.
 
17. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. AnnInternMed2007;146:317–325.
 
18. Maurer DM, Raymond TJ, Davis BN. Depression: screening and diagnosis. Am Fam Physician 2018;98:508–515.
 
19. Plummer F, Manea L, Trepel D, et al. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic meta analysis. Gen Hosp Psychiatry 2016;39: 24–31.
 
20. Hendrieckx C, Halliday JA, Russell-Green S, et al. Adults with diabetes distress often want to talk with their health professionals about it: findings from an audit of 4 Australian specialist diabetes clinics. Can J Diabetes 2020;44:473–480.